ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Rui Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5820-0177; OpenAlex author ID A5100725097. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2023: 1 paper

Papers 1

iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy Co-author DOI 10.21203/rs.3.rs-2470450/v1 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ting Deng · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Zhi Ji · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Duo Zuo · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Ning Wang · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Tiansuo Zhao · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗
Yi Ba · 1 shared paper, 2023 · strength 0.18
- Paper iRGD-modified exosomes encapsulate anti-miR-25-3p for targeted pancreatic cancer therapy DOI 10.21203/rs.3.rs-2470450/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.